Enhabit (EHAB) Surges 22.6%: Is This an Indication of Further Gains?
Enhabit (EHAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Despite Fast-paced Momentum, Enhabit (EHAB) Is Still a Bargain Stock
Enhabit (EHAB) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Enhabit (EHAB) Is Attractively Priced Despite Fast-paced Momentum
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
3 Medical Service Industry Stocks Set to Tackle Workforce Challenges
Medical services stocks like MEDP, EHAB and PGNY benefit from tech-driven care models even as staffing gaps pressure margins.
Enhabit (EHAB) Shows Fast-paced Momentum But Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?
Here is how Enhabit (EHAB) and Gain Therapeutics, Inc. (GANX) have performed compared to their sector so far this year.
Enhabit, Inc. (EHAB) Presents at Bank of America Home Care Conference Transcript
Enhabit, Inc. (EHAB) Presents at Bank of America Home Care Conference Transcript
Are Medical Stocks Lagging Enhabit, Inc. (EHAB) This Year?
Here is how Enhabit (EHAB) and Ensign Group (ENSG) have performed compared to their sector so far this year.
Fast-paced Momentum Stock Enhabit (EHAB) Is Still Trading at a Bargain
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Enhabit, Inc. (EHAB) Presents at UBS Global Healthcare Conference 2025 Transcript
Enhabit, Inc. ( EHAB ) UBS Global Healthcare Conference 2025 November 11, 2025 12:30 PM EST Company Participants Barbara Jacobsmeyer - President, CEO & Director Ryan Solomon - Chief Financial Officer Presentation Operator All right. I think we're getting to get started here.
Enhabit (EHAB) Upgraded to Buy: Here's What You Should Know
Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Enhabit (EHAB) Surpasses Q3 Earnings Estimates
Enhabit (EHAB) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.03 per share a year ago.
